Appendiceal Carcinoma: A Diagnostic and Therapeutic Challenge

References

• Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998; 41(1): 75–80.
   PubMed Web of Science ®Google Scholar
• Nitecki SS, Wolff BG, Schlinkert R, Sarr MG. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg. 1994; 219(1): 51–57.
   Google Scholar
• Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol. 1997; 16(1): 1–9.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Andrabi SI, Thekkinkattil DK, Rathore MA. Adenocarcinoid tumour of the appendix masquerading as acute appendicitis: a word of caution. Ulus Travma Acil Cerrahi Derg. 2008; 14(2): 167–169.
   Google Scholar
• Deraco M, Laterza B, Kusamura S, Baratti D. Updated treatment of peritoneal carcinomas: a review. Minerva Chir. 2007; 62(6): 459–476.
   Google Scholar
• Ahmed K, Hoque R, El-Tawil S, Khan MS, George ML. Adenocarcinoma of the appendix presenting as bilateral ureteric obstruction. World J Surg Oncol. 2008; 6: 23.
   Google Scholar
• Arisawa C, Takeuchi S, Wakui M. Appendiceal carcinoma invading the urinary bladder. Int J Urol. 2001; 8(4): 196–198.
   Google Scholar
• Mori N, Noma M, Hara T, et al. A case of mucinous cystadenocarcinoma of the appendix penetrating the urinary bladder. Hinyokika Kiyo. 2002; 48(6): 351–354.
   Google Scholar
• Brendan MJ, Cecil TD. The etiology, clinical presentation and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003; 12: 585–603.
   Google Scholar
• Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Schmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei.” Am J Surg Pathol. 1995; 19(21): 1390–1408.
   Google Scholar
• Harshen R, Jyothirmayi R, Mithal M. Pseudomyxoma peritonei: an overview. Clin Oncol. 2003; 15(2): 73–77.
   Google Scholar
• Colquhoun P, Weiss EG, Efron J, Nogueras JJ, Vernava AM 3rd, Wexner SD. Colorectal cancer screening: do we practice what we preach? Surg Innov. 2006; 13(2): 81–85.
   Google Scholar
• Holcomb SS. Colorectal cancer: new screening guideline. Nurse Pract. 2008; 33(9): 13–19.
   Google Scholar
• Fornaro R, Frascio M, Sticchi C, et al. Appendectomy or right hemi-colectomy in the treatment of appendiceal carcinoid tumors? Tumori. 2007; 93(6): 587–590.
   Google Scholar
• Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006; 7(1): 69–76.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007; 245(1): 104–109.
   PubMed Web of Science ®Google Scholar
• Culliford AT 4th, Brooks AD, Sharma S, et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol. 2001; 8(10): 787–795.
   PubMed Web of Science ®Google Scholar
• Stewart JH 4th, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006; 13(5): 624–634.
   Google Scholar
• McCusker ME, Coté TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer. 2002; 94(12): 3307–3312.
   PubMed Web of Science ®Google Scholar
• Yantiss RK, Shia J, Klimstra DS, Hahn HP, Odze RD, Misdraji J. Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms [published online ahead of print, Oct 10, 2008], Am J Surg Pathol.
   Google Scholar
• Proulx GM, Willett CG, Daley W, Shellito PC. Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy. J Surg Oncol. 1997; 66(1): 51–53.
   Google Scholar
• Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005; 241(2): 300–308.
   PubMed Web of Science ®Google Scholar
• Eng C, Shapiro J, Wolff R, et al. Is systemic chemotherapy a viable option for patients with appendiceal epithelial neoplasms (AEN)? Multidisciplinary approaches to the prevention, diagnosis, and therapy of GI cancers. Gastrointestinal Cancers Symposium. 2007; A363.
   Google Scholar
• Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg. 1995; 19(2): 235–240.
   Google Scholar
• Walko CM, Lindley C. Capecitabine: a review. Clin Ther. 2005; 27(1): 23–44.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Chu E. An update on treatment advances for the first-line therapy of metastatic colorectal cancer. Cancer J. 2007; 13(5): 276–281.
   Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus iri-notecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23): 2335–2342.
   PubMed Web of Science ®Google Scholar
• Kalofonos HP, Grivas PD. Monoclonal antibodies in the management of solid tumors. Curr Top Med Chem. 2006; 6(16): 1687–1705.
   Google Scholar
• Jocelyn M, Logan-Collins, Lowy AM, et al. VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol. 2008; 15(3): 738–744.
   Google Scholar